NCT05862493

Brief Summary

The primary objective of this study is to investigate the impact of preoperative focused transthoracic ultrasound (FOCUS) on intraoperative hypotension and postoperative complications in hip fracture surgery. Our hypothesis is that a preoperative FOCUS along with a hemodynamic optimization protocol will reduce the occurrence of intraoperative drops in blood pressure and post-operative complications.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Feb 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

April 27, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 17, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

December 8, 2023

Status Verified

December 1, 2023

Enrollment Period

2 years

First QC Date

April 27, 2023

Last Update Submit

December 7, 2023

Conditions

Keywords

FOCUSPoint-of-care echocardiography

Outcome Measures

Primary Outcomes (1)

  • Blood pressure drop

    Intraoperative drop in blood pressure defined as mean arterial pressure (MAP) \< 60 mmHg

    From date of randomization up to 4 hours

Secondary Outcomes (6)

  • Change of blood pressure level

    From date of randomization up to 4 hours

  • Lowest level of blood pressure (MAP)

    From date of randomization up to 4 hours

  • Acute kidney failure

    From date of randomization up to 48 hours

  • Myocardial injury

    From date of randomization up to 48 hours

  • Readmission

    From date of randomization up to 7 days

  • +1 more secondary outcomes

Study Arms (2)

Standard management

NO INTERVENTION

Standard preoperative management, no preoperative TTE

FOCUS optimization

EXPERIMENTAL

Standard preoperative management AND preoperative FOCUS along with an individualized hemodynamic optimization based on FOCUS findings.

Diagnostic Test: FOCUS echocardiography

Interventions

FOCUS echocardiographyDIAGNOSTIC_TEST

Preoperative FOCUS echocardiography. Based on FOCUS information: correction of low level of venous return and/or step-up monitoring and/or vasoactive drugs

FOCUS optimization

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients ≥ 65 years of age, with American Socieity of Anesthesiologists (ASA) physical status classification 2-4, that are scheduled for acute hip fracture surgery (ICD-codes s72.0, s72.00, s72.01, s72.1, s72.2)

You may not qualify if:

  • Metastatic cancer and/or suspect pathological fracture.
  • Concurrent other fracture/surgery.
  • Reoperation within 72 hours from primary operation.
  • Severe dementia.
  • Preoperative echocardiography for other reason than participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Tomi P Myrberg, MD, PhD

    Umeå University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tomi P Myrberg, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Blinded data analysis
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a randomized, open label, superiority trial with a 1:1 allocation ratio
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2023

First Posted

May 17, 2023

Study Start

February 1, 2024

Primary Completion

February 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 8, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

SPSS data file will be available for a reasonable request